Diversified Trust Co Sells 4,509 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Diversified Trust Co lessened its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 29.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,558 shares of the biotechnology company's stock after selling 4,509 shares during the period. Diversified Trust Co's holdings in Axon Enterprise were worth $6,275,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in AXON. Groupama Asset Managment purchased a new stake in shares of Axon Enterprise during the 3rd quarter valued at about $200,000. Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise during the third quarter valued at approximately $120,553,000. International Assets Investment Management LLC acquired a new position in shares of Axon Enterprise during the third quarter worth $871,860,000. Westfield Capital Management Co. LP boosted its stake in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock valued at $469,661,000 after purchasing an additional 127,769 shares during the period. Finally, 1832 Asset Management L.P. grew its holdings in Axon Enterprise by 44.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company's stock valued at $110,546,000 after purchasing an additional 114,800 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

AXON traded down $8.68 during trading on Tuesday, hitting $562.03. The stock had a trading volume of 934,648 shares, compared to its average volume of 875,260. The firm has a market cap of $42.86 billion, a PE ratio of 145.23, a P/E/G ratio of 14.19 and a beta of 1.04. The company has a 50 day simple moving average of $598.56 and a 200-day simple moving average of $445.07. Axon Enterprise, Inc. has a 12 month low of $244.01 and a 12 month high of $698.67. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Activity

In other news, Director Michael Garnreiter sold 1,000 shares of the firm's stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares of the company's stock, valued at approximately $11,500,916.82. This trade represents a 3.67 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business's stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares in the company, valued at $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 51,545 shares of company stock worth $31,159,317. Company insiders own 6.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. The Goldman Sachs Group raised their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a "buy" rating in a research note on Wednesday, October 23rd. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a research report on Monday, November 11th. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Needham & Company LLC lifted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Finally, Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, Axon Enterprise has an average rating of "Moderate Buy" and an average price target of $488.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.